Aug 2018: New investors come onboard

Updated: Jan 8

LIQID Medical is pleased to welcome two new VC investors in preparation for the OptiShunt First-in-Man clinical trials commencing soon.


Glaucoma remains a leading cause of blindness worldwide, affecting over 70 million people

Contact

Dr Daemon McClunan, Founder
email: daemon@liqidmedical.com

mobile: +27 (0)84 604 7600

location: Cape Town, South Africa

You Tube icon white edited

© 2017 Copyright reserved. Online Solutions by CassandraGroenewald.com